According to the Chinese Glioma Genome Atlas (CGGA) database and the qRT-PCR results, we found that MET expression levels were higher in recurrent GBM samples than in primary GBM samples (Supplementary Fig. 8a, b). The gene discussed is MET; the disease is glioma.